Clinical Trial Update: An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravenous zoledronic acid given twice yearly for osteoporosis in children on glucocorticoids; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2019-07-05